Search

Your search keyword '"Vikki Rand"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Vikki Rand" Remove constraint Author: "Vikki Rand"
58 results on '"Vikki Rand"'

Search Results

1. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement

2. Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif

3. Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

4. Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity

5. Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement

6. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia

7. Spatial and molecular profiling of the mononuclear phagocyte network in Classic Hodgkin lymphoma

8. Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma development

9. Spatial and molecular profiling reveals an immunosuppressive mononuclear phagocyte network in Classic Hodgkin lymphoma

11. TP53 STATUS RISK STRATIFIES PATIENTS WITH CLINICALLY DEFINED HIGH-RISK DISEASE PAEDIATRIC B-CELL NON-HODGKIN LYMPHOMA

12. Spatial and molecular profiling of classic Hodgkin lymphoma reveals an immunosuppressive mononuclear phagocyte network

13. Spatial and molecular profiling of the classic Hodgkin lymphoma microenvironment reveals an immunosuppressive mononuclear phagocyte network

14. PTU-78 GI and Non-GI manifestations of COVID-19 during first wave of the pandemic at Darlington, UK

15. Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif

16. Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma

17. Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children

18. A Prospective Cohort Analysis of COVID-19 Positive and Negative Patients Admitted to a Single Centre in the North-East of England During the Peak of a Pandemic

19. Sequential Inverse Dysregulation of the RNA Helicases DDX3X and DDX3Y Facilitates MYC-Driven Lymphomagenesis

20. Abstracts

21. Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia

22. Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis

23. Abstract PO-19: Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis

25. MBRS-59. SINGLE-CELL WHOLE-GENOME SEQUENCING DISSECTS INTRA-TUMOURAL GENOMIC HETEROGENEITY AND CLONAL EVOLUTION IN CHILDHOOD MEDULLOBLASTOMA

26. DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia

27. Sporadic and endemic Burkitt lymphoma have frequent

28. Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens

29. Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

30. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint

31. Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity

32. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma

33. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia

34. Abstracts from the 2009 Joint Meeting of the Society for Neuro-Oncology (SNO) and the American Association of Neurological Surgeons/Congress of Neurological Surgeons (AANS/CNS) Section on Tumors

35. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

36. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma

37. Abstracts from the Thirteenth International Symposium on Pediatric Neuro-Oncology

38. Gene map of the extended human MHC

39. Estrogen receptor ligands affect mitochondrial activity in SH-SY5Y human neuroblastoma cells

40. Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia

41. Cross-species genomics matches driver mutations and cell compartments to model ependymoma

42. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

43. A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse

44. PIK3CA gene mutations in pediatric and adult glioblastoma multiforme

45. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas

46. High BACH2 gene Expression Is an Indicator of Poor Prognosis in Adult Diffuse Large B-Cell Lymphoma Treated with R-CHOP

47. Development of in Vivo Models of Paediatric Burkitt Lymphoma Allowing Therapeutic Target Analysis and Drug Testing

48. The Genomic Landscape of Relapsed B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in Adolescents and Adults

49. The Genomic Landscape Of Lineage Switch Acute Leukemia

50. Epstein-Barr virus–independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency

Catalog

Books, media, physical & digital resources